Sort
23,748 grants matching “melanoma”
Precision Medicine For Pediatric Low-Grade Gliomas
$520,926Daphne A. Haas-Kogan · Dana-Farber Cancer Inst · R01 · FY2019 · NS
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$520,857Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$520,857Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$520,857Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Pathology and Bioinformatics Core
$520,743Scott J Rodig · Massachusetts General Hospital · P01 · FY2025 · CA
Localized immunotherapy using alum-binding therapeutics
$520,695Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2022 · EB
Harnessing NKT Cell Activation by Glycolipids
$520,591Amy R. Howell · University Of Connecticut Storrs · R01 · FY2020 · GM
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · CA
Novel Strategies for Precision T-cell Therapies
$520,564Steven C. Almo · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · CA
Developing new therapeutic strategies for brain metastasis
$520,544Eva Hernando · New York University School Of Medicine · R01 · FY2024 · CA
Upgrading rigor and efficiency of germline cancer gene variant classification for the 2020s
$520,538Sean Vahram Tavtigian · University Of Utah · R01 · FY2024 · CA
A comparison of interventions to teach patients skin self-examination
$520,493June K Robinson · Northwestern University At Chicago · R01 · FY2019 · CA
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
$520,435Emily H Cheng · Sloan-Kettering Inst Can Research · U54 · FY2024 · CA
Regulatory Network Differences/Diverse Tumor Subtypes/Design Combinatorial Therap
$520,350Chris Sander · Sloan-Kettering Inst Can Research · U54 · FY2013 · CA
Glycosylation Mutants of Mice and Animal Cells
$520,266Pamela M Stanley · Albert Einstein College Of Medicine · R01 · FY2009 · CA
Functional and Therapeutic Significance of PLK4 in Melanoma
$520,204Nihal Ahmad · University Of Wisconsin-Madison · R01 · FY2024 · CA
Precision Medicine For Pediatric Low-Grade Gliomas
$520,168Daphne A. Haas-Kogan · Dana-Farber Cancer Inst · R01 · FY2017 · NS
Epigenetic Mechanisms of Gene Expression in Lung Cancer Cells
$520,139David Schrump · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Evaluation of treatment predictors reflecting beta-catenin activation in hepatocellular carcinoma
$520,008Sandi Alexander Kwee · Queen'S Medical Center · R01 · FY2021 · CA
Immunological Monitoring & Cellular Products
$519,862Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · CA
INTRAVITAL IMAGING OF MELANOMA TUMORS FOR MECHANISM DISCOVERY AND PATIENT SURVEILLANCE AFTER CHECKPOINT BLOCKADE IMMUNOTHERAPY
$519,854University Of California Irvine · · FY2025 · Defense Health Agency
Role of inflammation, innate resistance, and immunity in carcinogenesis
$519,797Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
NONCALCEMIC VITAMIN D-HYDROXY DERIVATIVES AS PREVENTIVE AND THERAPEUTIC AGENTS IN UVB-INDUCED MELANOMA
$519,750University Of Alabama At Birmingham · · FY2022 · Defense Health Agency
NON-CALCEMIC VITAMIN D-HYDROXYDERIVATIVES AS PREVENTIVE AND THERAPEUTIC AGENTS IN UVB-INDUCED MELANOMA
$519,747Oregon State University · · FY2022 · Defense Health Agency